LIBERTA will launch 2 serums from its MEDiLiA brand, P-DRN Shot and Azela Shot, with an advance release on 2 November and nationwide sales beginning on 16 November. They will debut on Qoo10 on 10 November, with advance launches also planned at LOFT and @cosme.
Two skin-enhancing serums from MEDiLiA, a new brand inspired by aesthetic treatments, will launch: P-DRN Shot and Azela Shot. The advance launch is scheduled for 2 November through LOFT and @cosme, followed by a Qoo10 debut on 10 November. From 16 November, the products will be available at variety stores nationwide, selected drugstores, the official online store and e-commerce marketplaces.
P-DRN Shot uses “silk water” as a substitute for water, a world first, and contains PDRN and RejuveNAD to support skin firmness and elasticity. Azela Shot combines Epi-on with fermented ceramide water and was designed as an aftercare-focused serum inspired by aesthetic treatments, with an emphasis on balancing and moisturizing unsettled skin and conditioning it.
The 2 products in the November general-release lineup are P-DRN Shot (marketing name: PN Silk Shot) and Azela Shot (marketing name: Azela Shot). Each sachet contains 1 mL. The products are available in 28-sachet packs priced at ¥2,970 including tax and 7-sachet packs priced at ¥990.
The ingredients described for P-DRN Shot are PDRN, RejuveNAD and silk water, while those described for Azela Shot are Epi-on, fermented ceramide water and allantoin. These ingredients are included to enhance moisture and suppleness in the stratum corneum.
MEDiLiA highlights 3 defining features: one-shot products inspired by aesthetic treatments, the delivery of fresh ingredients with each use, and highly portable individual sachets. The products use an aqua-minimal formulation designed to minimize the use of water.